CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Nov. 9, 2020—TechLab has partnered with the New River Valley COVID-19 Task Force to expand future COVID-19 testing capacity. Under the agreement, the New River Health District, headquartered in Christianburg, Va., secures access to TechLab’s analyte-specific reagents for SARS-CoV-2 for $7 to $9 per use.
“As a company founded and headquartered here in the New River Valley, we are proud to work closely with public health officials to provide a cost-effective and flexible option to increase their COVID-19 testing,” Joel Herbein, PhD, vice president of scientific affairs at TechLab, said in a press statement. “Our analyte-specific reagents can be used now to maximize COVID-19 testing by any lab that is CLIA-certified to perform medium- and high-complexity testing. We are also incorporating our ASRs into 96-well and rapid antigen tests and plan to submit to the U.S. FDA for emergency use authorization.”